Recently we’ve had to familiarize ourselves with yet another virus, monkeypox. As of July 25,…
The FDA approved Ocrevus (ocrelizumab) as the first-ever drug to treat primary progressive multiple sclerosis (PPMS), a serious form of…
Data science could become a new tool to help researchers discover dangerous drug-drug interactions that have yet to come to…
MedShadow Foundation is an independent nonprofit health & wellness journalism organization focused on helping to protect lives from the side effects of medication and lower risk alternative health options.
We help protect your life and the lives of your family by making sure you have the information you need to make informed decisions about the risks, benefits and alternatives to medicines.
Even though MedShadow is nonprofit, we refuse to accept support from pharmaceutical companies or medical device manufacturers. You can be sure that our information is free from the influence of pharmaceutical companies.
Symptoms & Concerns
MedShadow Foundation does not provide medical advice, diagnosis or treatment.
This site complies with the HONcode standard for trustworthy health information: verify here.
MedShadow Foundation is a registered 501(c)(3) non-profit organization. MedShadow does not accept advertising or contributions from pharmaceutical companies, medical device manufacturers or political action organizations.
Copyright © 2022, MedShadow Foundation. all rights reserved. Designed by Dante Steward